4
Changes in Ownership
ENDONOVO THERAPEUTICS, INC. Filed Acc 0001645470-19-000043
CEO bought 96,000 shares at an average $0.01 ($1,186)
From the SEC's structured data for this filing
Trades in this filing
Collier Alan Brian · CEO
Table I: Non-derivative
16 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-07-16 | Purchase : show line 1 in the form | +5,000 | $0.01 | $71 | 24,767,797 | D |
| 2019-07-17 | Purchase : show line 2 in the form | +2,000 | $0.01 | $28 | 24,769,797 | D |
| 2019-07-17 | Purchase : show line 3 in the form | +5,000 | $0.01 | $69 | 24,774,797 | D |
| 2019-07-17 | Purchase : show line 4 in the form | +10,000 | $0.01 | $139 | 24,784,797 | D |
| 2019-07-17 | Purchase : show line 5 in the form | +10,000 | $0.01 | $140 | 24,794,797 | D |
| 2019-07-17 | Purchase : show line 6 in the form | +1,000 | $0.01 | $14 | 24,795,797 | D |
| 2019-07-18 | Purchase : show line 7 in the form | +10,000 | $0.01 | $111 | 24,805,797 | D |
| 2019-07-18 | Purchase : show line 8 in the form | +10,000 | $0.01 | $111 | 24,815,797 | D |
| Open-market purchases · 96,000 sh · avg $0.01 · $1,186 | ||||||
Loading xslF345X03/primary_doc.xml…